Skip to main content

What the FDA labels say about taking them together

Ivacaftor and posaconazole

Ivacaftor's FDA label of March 23, 2026 names posaconazole in its drug interactions section; the posaconazole labels PlainMeds reads (2) do not name ivacaftor. The ivacaftor label: “… concomitant strong CYP3A inhibitors, such as ketoconazole, itraconazole, posaconazole, voriconazole, telithromycin, and clarithromycin.”

Check it at the source: the ivacaftor FDA label on DailyMed (effective March 23, 2026, Vertex Pharmaceuticals Incorporated); the posaconazole FDA label on DailyMed (effective August 3, 2026, Aurobindo Pharma Limited).

What does the ivacaftor label say about posaconazole?

Ivacaftor label, drug interactions

Based on simulations of these results, a reduction of the KALYDECO dosage is recommended for patients aged 6 months and older taking concomitant strong CYP3A inhibitors, such as ketoconazole, itraconazole, posaconazole, voriconazole, telithromycin, and clarithromycin.

Source: FDA drug label (Kalydeco), Vertex Pharmaceuticals Incorporated, effective March 23, 2026 (SPL set 0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25), via openFDA; the full label on DailyMed

What does the posaconazole label say about ivacaftor?

Posaconazole's label (effective August 3, 2026) and its 1 other brand-application label do not name ivacaftor in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (POSACONAZOLE), Aurobindo Pharma Limited, effective August 3, 2026 (SPL set f8a26673-261c-4e8e-b1e1-9e23aaf7f285), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Ivacaftor generic labelers
27Posaconazole generic labelers
IvacaftorPosaconazole
Labeled forn/aFungal infections
Boxed warningNoNo
Pharmacy cost (NADAC)n/a$2.03 per tablet 100 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?